Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth |
---|
hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/capsule-classification-category | Capsule Shell Classification Terminology | trial-use | 2 | brr | 2025-07 | hl7 |
hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/pqcmc-coating-purpose | Coating Purpose Terminology | trial-use | 2 | brr | 2025-07 | hl7 |
hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/pqcmc-product-part-ingredient-physical-location | Ingredient Location Terminology | trial-use | 2 | brr | 2025-07 | hl7 |
hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/pqcmc-product-part-type | Product Part Type Terminology | trial-use | 2 | brr | 2025-07 | hl7 |
hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/pqcmc-substance-name-type | Substance Name Type | trial-use | 2 | brr | 2025-07 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7597 | Work Classification (ODH) | active | | | 2020-01 | |
hl7.fhir.us.breastcancer | R3 | ValueSet/cimi-context-PresenceContextVS | BC PresenceContextVS ValueSet | draft | | | 2018-08 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.827 | Diagnosis Type (HL7) | active | | | 2008-01 | |
hl7.fhir.us.pdmp | R4 | ValueSet/pdmp-patient-alert-category-code | PDMP Value Set - Patient Alert Category Code | active | | phx | 2024-04 | hl7 |
fhir.org.nz.ig.base | R4 | ValueSet/maori-descent-valueset | Māori Descent | active | | | 2025-06 | hl7 |
hl7.fhir.us.breastcancer | R3 | ValueSet/cimi-entity-LanguageQualifierVS | BC LanguageQualifierVS ValueSet | draft | | | 2018-08 | hl7 |
fhir.org.nz.ig.base | R4 | ValueSet/practitioner-additional-authorisation-code | Additional Practitioner authorisations | active | | | 2025-06 | hl7 |
fhir.org.nz.ig.base | R4 | ValueSet/practitioner-scope-of-practice | Scope of practice | active | | | 2025-06 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7593 | Consolidated Race (NCHS) | active | | | 2017-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7578 | Consolidated Ethinicity (NCHS) | active | | | 2017-01 | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.1.11.20275 | HealthcareServiceLocation | active | | | 2024-06 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1057 | Vaccine Contraindications | active | | | 2008-01 | |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-histologic-behavior-and-type-vs | Histologic Behavior and Type Value Set | active | | cic | 2025-02 | hl7 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-histologic-grading-system-vs | Histologic Grading System Value Set | active | | cic | 2025-02 | hl7 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-histologic-grade-vs | Histologic Grade Value Set | active | | cic | 2025-02 | hl7 |
hl7.fhir.us.directory-query | R4 | ValueSet/InsuranceProductTypeVS | Insurance Product Type Value Set | active | | | 2022-12 | hl7 |
hl7.fhir.us.davinci-pdex-plan-net | R4 | ValueSet/InsuranceProductTypeVS | Insurance Product Type VS | trial-use | | fm | 2025-02 | hl7 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/limited-life-expectancy-conditions | Limited life expectancy conditions | active | | | 2023-05 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.11.20.9.69.1.3 | Advance Care Planning Services Grouping | active | | | 2022-03 | hl7 |
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-ari-test-codes | resp-net-ari-test-codes | draft | | | 2023-08 | hl7 |
hl7.fhir.us.illTraveler | R4 | ValueSet/AirportCodeVS | Airport Codes VS | draft | | | 2024-03 | hl7 |
hl7.fhir.us.illTraveler | R4 | ValueSet/PortHealthStationVS | Port Health Stations VS | draft | | | 2024-03 | hl7 |
hl7.fhir.us.illTraveler | R4 | ValueSet/InfectiousDiseaseNameVS | Infectious Disease VS | draft | | | 2024-03 | hl7 |
hl7.fhir.us.illTraveler | R4 | ValueSet/TuberculosisVS | Tuberculosis VS | draft | | | 2024-03 | hl7 |
hl7.fhir.us.davinci-dtr | R4 | ValueSet/metric-launchmode | Metric Launch Mode | trial-use | 2 | cds | 2025-07 | hl7 |
hl7.fhir.us.davinci-dtr | R4 | ValueSet/metric-Action | Metric Action | trial-use | 2 | cds | 2025-07 | hl7 |
hl7.fhir.us.davinci-pas | R4 | ValueSet/MetricDataSource | Metric Data Source | trial-use | 3 | fm | 2025-07 | hl7 |
hl7.fhir.us.davinci-crd | R4 | ValueSet/metricDataSource | CRD Metric Data Source Value Set | trial-use | 1 | fm | 2025-07 | hl7 |
hl7.fhir.us.davinci-dtr | R4 | ValueSet/metric-Source | Metric Source | trial-use | 2 | cds | 2025-07 | hl7 |
hl7.fhir.us.davinci-crd | R4 | ValueSet/metricTokenUse | CRD Metric Token Use | trial-use | 1 | fm | 2025-07 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7964 | US Vital Records Jurisdictions (NCHS) | active | | | 2020-01 | |
fhir.virtually.healthcare | R4 | ValueSet/MedicalRecordSystem | Medical Record System | draft | | | 2025-07 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7438 | Application Error Code (NCHS) | active | | | 2017-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7513 | Message Error Condition Codes (NCHS) | active | | | 2017-01 | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.11.20.9.69.1.1 | Advance Care Planning Services CPT | active | | | 2018-01 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.11.20.9.69.1.2 | Advance Care Planning Services SCT | active | | | 2018-01 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1042 | Specimen Condition | active | | | 2008-01 | |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-cancer-stage-value-vs | Cancer Stage Value Set | active | | cic | 2025-02 | hl7 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-risk-assessment-vs | Risk Assessment Value Set | active | | cic | 2025-02 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.305 | Organisms (Tests by Microscopic Observation in Specimen from Normally Sterile Site by Gram Stain) | active | | | 2025-02 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7129 | Employment Status (ODH) | active | | | 2020-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.113883.1.11.10416 | Financially Responsible Party Type Value Set | active | | | 2009-01 | |
hl7.fhir.us.covid19library | R4 | ValueSet/covid-19-icd-diagnosis-vs | COVID-19 ICD 10 Diagnosis Value Set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-who-path-la-codes-value-set | World Health Organization, COVID-19 variant LOINC answer code value set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/sars-cov2-rdrp-mutation-vs | SARS CoV 2 RdRp Gene Mutation value set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/sars-cov2-clade-loinc-answer-value-set | SARS CoV 2 Clade Assignment LOINC Answer value set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-detected-genetic-mutation-la-codes-value-set | Detected Genetic Mutations LOINC answer codes value set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/sars-cov2-lineage-loinc-answer-value-set | SARS CoV 2 Lineage LOINC Answers | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/exposure-type-la-value-set | Exposure Type LOINC Answer Value Set | active | | | 2022-07 | hl7 |
hl7.fhir.us.cimilabs | R4 | ValueSet/loinc-doc-value-set | LOINC Document class value set | draft | | | 2023-08 | hl7 |
hl7.fhir.us.cimilabs | R4 | ValueSet/standard-lab-obs-narrative-value-set | Standard Lab Obs Narrative value set | draft | | | 2023-08 | hl7 |
hl7.fhir.us.cimilabs | R4 | ValueSet/standard-lab-obs-quantitative-value-set | Standard Lab Obs Quantitative Code value set | draft | | | 2023-08 | hl7 |
hl7.fhir.us.cimilabs | R4 | ValueSet/StdLabObsCoded-value-set | Standard Coded Lab Observation Code value set | draft | | | 2023-08 | hl7 |
hl7.fhir.us.cimilabs | R4 | ValueSet/StdLabObsOrdinal-value-set | Standard Coded Ordinal Lab Observation Code value set | draft | | | 2023-08 | hl7 |
hl7.fhir.us.cimilabs | R4 | ValueSet/lab-result-code-value-set | Lab Result Code value set | draft | | | 2023-08 | hl7 |
hl7.fhir.us.cimilabs | R4 | ValueSet/titer-lab-codes-value-set | Titer Lab Codes value set | draft | | | 2023-08 | hl7 |
hl7.fhir.us.core | R4 | ValueSet/us-core-servicerequest-category | US Core ServiceRequest Category Codes | trial-use | 3 | cgp | 2022-09 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid-19-snomed-diagnosis-vs | COVID-19 SNOMED CT Diagnosis Value Set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-underlying-medical-condition-vs | COVID-19 Underlying Medical Condition Value Set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/reactive-non-reactive-value-set | Reactive - Non-reactive value set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-reporting-priority-vs | Reporting Priorities Value Set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-det-notdet-eq-inc-vs | Detected, Not Detected, Inconclusive Value Set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-pos-neg-eqvs | Positive/Negative Value Set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/fluAB-SARSCoV2-value-set | Influenza A, Influenza B, and SARS CoV2 value set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/fluAB-SARSCoV2-SARSCoV-value-set | Influenza A, Influenza B, SARS CoV 2, and SARS CoV value set | active | | | 2022-07 | hl7 |
hl7.fhir.us.cimilabs | R4 | ValueSet/ordinal-value-code-value-set | Ordinal Value Code value set | draft | | | 2023-08 | hl7 |
hl7.fhir.us.cimilabs | R4 | ValueSet/abnormal-interpretation-value-set | Abnmormal Interpretation value set | draft | | | 2023-08 | hl7 |
hl7.fhir.us.cimilabs | R4 | ValueSet/null-flavor-value-set | Null Flavor value set | draft | | | 2023-08 | hl7 |
hl7.fhir.us.cimilabs | R4 | ValueSet/abnml-int-numeric-nom-value-set | Abnormal Interpretation Numeric Nominal value set | draft | | | 2023-08 | hl7 |
hl7.fhir.us.vrdr | R4 | ValueSet/vrdr-manner-of-death-vs | Manner of Death ValueSet | active | | pher | 2024-10 | hl7 |
hl7.fhir.us.cimilabs | R4 | ValueSet/units-of-measure-value-set | Units of Measure value set | draft | | | 2023-08 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-underlying-uncategorized-condition-value-set | COVID-19 uncategorized underlying condition reference set | active | | | 2022-07 | hl7 |
hl7.fhir.us.lower-extremity-skin-wound-assessment | R4 | ValueSet/communicationModeVS | CommunicationMode | draft | | | 2022-11 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-underlying-respiratory-condition-value-set | COVID-19 respiratory underlying condition reference set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-underlying-cardiovascular-condition-value-set | COVID-19 cardiovascular underlying condition reference set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-underlying-neurolgic-condition-value-set | COVID-19 neurologic underlying condition reference set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-underlying-gastrointestinal-hepatic-condition-value-set | COVID-19 gastrointestinal or hepatic underlying condition reference set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid91-underlying-hemoglobinopathy-condition-value-set | COVID-19 hemoglobinopathy underlying condition reference set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-underlying-immunocompromised-condition-value-set | COVID-19 immunocompromised underlying condition reference set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-underlying-immune-condition-value-set | COVID-19 immune underlying condition reference set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-underlying-metabolic-condition-value-set | COVID-19 metabolic underlying condition reference set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-underlying-renal-condition-value-set | COVID-19 renal underlying condition reference set | active | | | 2022-07 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-react-nonreact-borderline-inv-value-set | Reactive, Non-reactive, Borderline, Invalid value set | active | | | 2022-07 | hl7 |
hl7.fhir.us.vrdr | R4 | ValueSet/vrdr-death-pregnancy-status-vs | Death Pregnancy Status ValueSet | active | | pher | 2024-10 | hl7 |
hl7.fhir.us.vr-common-library | R4 | ValueSet/ValueSet-partial-date-data-absent-reason-vr | Value Set - Partial Date/DateTime Data Absent Reason Vital Records | active | | pher | 2025-05 | hl7 |
hl7.fhir.us.vr-common-library | R4 | ValueSet/ValueSet-yes-no-not-applicable-vr | Value Set - Yes No Not Applicable Vital Records | active | | pher | 2025-05 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7907 | Ethnicity (ARLN) | active | | | 2019-01 | |
hl7.fhir.us.immds | R4 | ValueSet/ForecastStatus | Forecast Status | active | | | 2021-06 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-pos-neg-inv-incl-vs | COVID19 Positive, Negative, Invalid, Inconclusive value set | active | | | 2022-07 | hl7 |
hl7.fhir.us.immds | R4 | ValueSet/StatusReason | Evaluation Status Reason | active | | | 2021-06 | hl7 |
hl7.fhir.us.immds | R4 | ValueSet/ForecastReason | Forecast Reason | active | | | 2021-06 | hl7 |
hl7.fhir.us.covid19library | R4 | ValueSet/covid19-cvx-codes-value-set | COVID 19 CVX Code System Vaccine Codes | active | | | 2022-07 | hl7 |
hl7.fhir.us.immds | R4 | ValueSet/targetDisease | Vaccine Target Disease | active | | | 2021-06 | hl7 |
hl7.fhir.us.breastcancer | R3 | ValueSet/shr-core-PerformanceGradingScaleVS | BC PerformanceGradingScaleVS ValueSet | draft | | | 2018-08 | hl7 |
hl7.fhir.us.physical-activity | R4 | ValueSet/pa-diagnosticreport-category | PA ServiceRequest Category - USCore | trial-use | 2 | pc | 2024-03 | hl7 |
fhir.nw-gmsa.nhs.uk | R4 | ValueSet/specimen-type | Specimen Type | draft | | | 2025-04 | hl7 |
hl7.fhir.us.vrdr | R4 | ValueSet/vrdr-edit-bypass-01-vs | Edit Bypass 01 | active | | pher | 2024-10 | hl7 |
hl7.fhir.us.vr-common-library | R4 | ValueSet/valueset-edit-bypass-01234-vr | Value Set - Edit Bypass 01234 Vital Records | active | | pher | 2025-05 | hl7 |
hl7.fhir.us.vrdr | R4 | ValueSet/vrdr-edit-bypass-0124-vs | Edit Bypass 0124 | active | | pher | 2024-10 | hl7 |
hl7.fhir.us.vrdr | R4 | ValueSet/vrdr-edit-bypass-012-vs | Edit Bypass 012 | active | | pher | 2024-10 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.918 | Admission Source (HL7) | active | | | 2019-01 | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.1.11.12199 | LanguageAbilityProficiency | active | | | 2024-06 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.1.11.12249 | LanguageAbilityMode | active | | | 2024-06 | hl7 |
fhir.nigeriaImmunization | R4 | ValueSet/IMMZD16-ValueSet | IMMZD16-ValueSet for AEFI Treatment | draft | | | 2025-05 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7913 | Candida auris PCR result (ARLN) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.113883.11.20.9.49 | Residence and Accommodation Type | active | | | 2014-12 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.113883.3.88.12.80.68 | Problem Status | active | | | 2014-12 | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.11.20.9.61 | Care Model | active | | | 2024-06 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.1.11.19185 | Religious Affiliation | active | | | 2024-06 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7909 | Identifier type (ARLN) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7920 | Interpretation codes (ARLN) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7270 | Lab Test Result Interpretation (NND) | active | | | 2020-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7904 | Program study or event (ARLN) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7914 | Acinetobacter culture result (ARLN) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7912 | Candida auris culture result (ARLN) | active | | | 2019-01 | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.11.20.7.1 | SupportedFileFormats | active | | | 2024-06 | hl7 |
hl7.fhir.us.spl | R5 | ValueSet/valueset-AllNDCProducts | All NDC Products | trial-use | 1 | brr | 2025-07 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7924 | Mother Infant Indicator (NND) | active | | | 2019-01 | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.1 | Pregnancy Status | active | | | 2023-08 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.10 | Pap Smear Tests | active | | | 2023-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.11 | HIV Tests | active | | | 2023-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.12 | Human Papilloma Virus Tests | active | | | 2023-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.13 | Chlamydia Trachomatis Tests | active | | | 2023-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.14 | Neisseria Gonorrhoeae Tests | active | | | 2023-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.17 | Contraceptive Type | active | | | 2023-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.18 | Contraception Not Used Reason | active | | | 2023-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.209 | Yes and No Answers | active | | | 2023-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.21 | Contraceptive Provision Method | active | | | 2023-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.210 | Pap Smear Results | active | | | 2023-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.211 | Contraceptive discussion | active | | | 2023-08 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.24 | Clinical Provider Role | active | | | 2023-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.29 | Insurance Coverage Type | active | | | 2023-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.3 | Organism Detection | active | | | 2023-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.31 | English Proficiency | active | | | 2023-07 | hl7 |
hl7.fhir.us.vitals | R4 | ValueSet/LowOnlyNumericResultIntVS | Low Only Numeric Result Interpretation value set | draft | | | 2024-10 | hl7 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/LesionComplexity | Complexity of the Lesion | active | | cic | 2023-11 | hl7 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/CABGIndication | CABG Indication | active | | cic | 2023-11 | hl7 |
hl7.fhir.us.medmorph | R4 | ValueSet/us-ph-computable-valueset-example | US Public Health Computable ValueSet Example | draft | | | 2022-07 | hl7 |
hl7.fhir.us.ecr | R4 | ValueSet/us-ph-computable-valueset-example | US Public Health Computable ValueSet Example | draft | | | 2022-05 | hl7 |
hl7.fhir.us.ph-library | R4 | ValueSet/us-ph-valueset-computable-example | US Public Health ValueSet - Computable Example | draft | | | 2022-07 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1562-laterality-from-landmark | RDE1562 Laterality from landmark | draft | | | 2022-10 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1565-type | RDE1565 Type | draft | | | 2022-10 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1568-distribution | RDE1568 Distribution | draft | | | 2022-12 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1571-associated-features | RDE1571 Associated features | draft | | | 2022-11 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1576-shape | RDE1576 Shape | draft | | | 2022-11 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1577-type | RDE1577 Type | draft | | | 2022-10 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1578-density | RDE1578 Density | draft | | | 2022-10 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1579-margin | RDE1579 Margin | draft | | | 2022-10 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1580-orientation | RDE1580 Orientation | draft | | | 2022-10 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1586-assessment-category | RDE1586 Assessment category | draft | | | 2022-11 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1587-breast-composition-category | RDE1587 Breast composition category | draft | | | 2022-11 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1588-breast-laterality | RDE1588 Breast laterality | draft | | | 2022-11 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1589-implant-presence | RDE1589 Implant presence | draft | | | 2022-11 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1590-prior-mastectomy | RDE1590 Prior mastectomy | draft | | | 2022-11 | hl7 |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1602-type | RDE1602 Type | draft | | | 2022-12 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1096 | Rash Syndrome (BT) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1089 | Botulism-like Syndrome (BT) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1099 | Specific Infection Syndrome (BT) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1091 | Gastrointestinal Syndrome (BT) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1097 | Respiratory Syndrome (BT) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1095 | Neurological Syndrome (BT) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1098 | Severe Illness Or Death Syndrome (BT) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1090 | Fever Syndrome (BT) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1094 | Lymphadenitis Syndrome (BT) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7702 | ATI Method (RIBD) | active | | | 2018-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3343 | Abnormal Flag (HL7 27) | active | | | 2010-01 | |
hl7.fhir.us.breast-radiology | R4 | ValueSet/rde1556-presence | RDE1556 Presence | draft | | | 2022-12 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1206.34 | AbnormalityOfGaitAndMobility | active | | | 2021-07 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3344 | Accept Application Acknowledgment Conditions (HL7) | active | | | 2017-01 | |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-tumor-size-units-vs | Tumor Size Units Value Set | active | 3 | cic | 2025-02 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.958 | Acknowledgment Code (HL7) | active | | | 2008-01 | |
signal.core.r4 | R4 | ValueSet/questionnaire-ccars-action-types | Questionnaire CCARS Action Types | draft | 1 | pa | | hl7 |
fhir.cqf.common | R4 | ValueSet/active-condition | CQF Active Condition | active | | | 2019-07 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.8014 | Activity Type Anthrax | active | | | 2020-01 | |
hl7.fhir.us.vrdr | R4 | ValueSet/vrdr-activity-at-time-of-death-vs | Activity at Time of Death ValueSet | active | | pher | 2024-10 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3102 | Skin Exposure Activity (FDD) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.8011 | Activity Type (Leptospirosis) | active | | | 2020-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7985 | Actual Route of Administration (Anthrax) | active | | | 2020-01 | |
hl7.fhir.us.nhsn-dqm | R4 | ValueSet/ach-encounter-class | Acute Care Hospital Encounter Class ValueSet | trial-use | 1 | pher | 2025-07 | hl7 |
hl7.fhir.us.nhsn-dqm | R4 | ValueSet/ach-encounter-status | Acute Care Hospital Encounter Status ValueSet | trial-use | 1 | pher | 2025-07 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3213 | Signs and Symptoms (Acute Hepatitis B) | active | | | 2009-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3206 | Lab Test Result Name (Acute Hepatitis B) | active | | | 2009-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3221 | Disease Type (Acute Hepatitis B) | active | | | 2009-01 | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.1.11.10416 | Financially Responsible Party Type Value Set | active | | | 2024-06 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.11.20.9.20 | Telecom Use (US Realm Header) | active | | | 2024-06 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.1.11.19579 | Family Member Value | active | | | 2024-06 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113883.11.20.9.38 | Smoking Status | active | | | 2024-06 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3162 | Risk Factors (TB) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.801 | Address Type (HL7) | active | | | 2018-01 | |
hl7.fhir.us.davinci-crd | R4 | ValueSet/locationAddressType | CRD Location Address Types Value Set | trial-use | 4 | fm | 2025-07 | hl7 |
hl7.fhir.us.davinci-hrex | R4 | ValueSet/hrex-coverage-relationship | HRex Coverage Relationship ValueSet | draft | 0 | cic | 2025-04 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.313 | Statin Allergen Grouping | active | | | 2024-03 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.113883.1.11.1 | Administrative Gender (HL7 V3) | active | | | 2019-01 | |
fhir.kisumuhie | R4 | ValueSet/gender-vs | Gender | draft | | | 2025-06 | hl7 |
fhir.kenyaPSIG | R4 | ValueSet/administrative-gender-vs | Administrative Gender | active | | | 2025-07 | hl7 |